...
首页> 外文期刊>Infection and immunity >Protection against experimental Pseudomonas aeruginosa infection by recombinant P. aeruginosa lipoprotein I expressed in Escherichia coli.
【24h】

Protection against experimental Pseudomonas aeruginosa infection by recombinant P. aeruginosa lipoprotein I expressed in Escherichia coli.

机译:通过在大肠杆菌中表达的重组铜绿假单胞菌脂蛋白I防止实验性铜绿假单胞菌感染。

获取原文
           

摘要

Lipoprotein I (OprI) is one of the major proteins of the outer membrane of Pseudomonas aeruginosa. OprI is a candidate for a vaccine against P. aeruginosa, because it cross-reacts antigenically in all serotype strains of the International Antigenic Typing Scheme. We recently cloned and expressed the gene coding for OprI in Escherichia coli. This heterologously expressed OprI was used successfully to immunize mice against P. aeruginosa. In addition, OprI from serogroup 12 of P. aeruginosa was highly purified by preparative isoelectric focusing and used for immunization of mice. Both vaccines protected the mice against a challenge with a four- to fivefold 50% lethal dose of P. aeruginosa.
机译:脂蛋白I(OprI)是铜绿假单胞菌外膜的主要蛋白之一。 OprI是抗铜绿假单胞菌疫苗的候选药物,因为它在国际抗原分型计划的所有血清型菌株中都具有抗原性交叉反应。我们最近在大肠杆菌中克隆并表达了编码OprI的基因。这种异源表达的OprI已成功用于免疫小鼠铜绿假单胞菌。另外,来自铜绿假单胞菌血清群12的OprI通过制备性等电聚焦被高度纯化,并用于免疫小鼠。两种疫苗都可以用致死剂量为铜绿假单胞菌四至五倍50%的杀伤剂保护小鼠。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号